| scholarly article | Q13442814 |
| P2093 | author name string | Richard L Jones | |
| James Stephen Krinsley | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | 644-650 | |
| P577 | publication date | 2006-03-01 | |
| P1433 | published in | Chest | Q5093377 |
| P1476 | title | Cost analysis of intensive glycemic control in critically ill adult patients. | |
| P478 | volume | 129 |
| Q33788963 | A Comparison of Inpatient Cost Per Day in General Surgery Patients with Type 2 Diabetes Treated with Basal-Bolus versus Sliding Scale Insulin Regimens |
| Q33514624 | A benchmark data set for model-based glycemic control in critical care |
| Q43156953 | Accuracy of different methods for blood glucose measurement in critically ill patients |
| Q37189275 | American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control |
| Q37813868 | Analytic review: glucose controversies in the ICU. |
| Q46071413 | Assessment of an educational intervention in the management of non-critical inpatient glycemic control |
| Q52877010 | Blood glucose control using a computer-guided glucose management system in allogeneic hematopoietic cell transplant recipients |
| Q34259198 | Breast Abscess, an Early Indicator for Diabetes Mellitus in Non‐lactating Women: A Retrospective Study from Rural India |
| Q42980115 | Close relationship between strict blood glucose control, including suppression of blood glucose variability, and mortality reduction in acutely ill patients with glucose intolerance investigated by means of a bedside-type artificial pancreas |
| Q41886516 | Continuous Insulin Infusion: When, Where, and How? |
| Q36633647 | Early versus late parenteral nutrition in ICU patients: cost analysis of the EPaNIC trial |
| Q41274819 | Economic benefits of intensive insulin therapy in critically Ill patients: the targeted insulin therapy to improve hospital outcomes (TRIUMPH) project |
| Q28068879 | Glucagon orchestrates stress-induced hyperglycaemia |
| Q38832644 | Glucose Control in the ICU: A Continuing Story |
| Q37635820 | Glucose control and its implications for the general surgeon. |
| Q86825092 | Glucose control in the critically ill. Innovations and contemporary strategies |
| Q37334028 | Glucose dysmetabolism and prognosis in critical illness |
| Q42241723 | Glycemia management in critical care patients |
| Q38012072 | Glycemic Management in the Inpatient Setting |
| Q37689885 | Glycemic control in the medical intensive care unit |
| Q34392352 | Hospital discharge algorithm based on admission HbA1c for the management of patients with type 2 diabetes |
| Q37205507 | How accurate are resting energy expenditure prediction equations in obese trauma and burn patients? |
| Q37329881 | Hyperglycemia management in the hospital: about glucose targets and process improvements |
| Q37626462 | Impact of human factors on clinical protocol performance: a proposed assessment framework and case examples |
| Q36749096 | Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: a clinical practice change |
| Q37391407 | In Silico Testing of an Artificial-Intelligence-Based Artificial Pancreas Designed for Use in the Intensive Care Unit Setting |
| Q46880889 | Insulin therapy in the intensive care unit should be targeted to maintain blood glucose between 4.4 mmol/l and 6.1 mmol/l |
| Q84922487 | Intensive Versus Conventional Insulin Therapy in Nondiabetic Patients Receiving Parenteral Nutrition After D2 Gastrectomy for Gastric Cancer: A Randomized Controlled Trial |
| Q38248149 | International multidisciplinary consensus conference on multimodality monitoring: ICU processes of care |
| Q41602012 | Is glycemic control of the critically ill cost-effective? |
| Q42963819 | Is there more to glycaemic control than meets the eye? |
| Q35739742 | Mild hypoglycemia is strongly associated with increased intensive care unit length of stay |
| Q49796040 | Next-generation, personalised, model-based critical care medicine: a state-of-the art review of in silico virtual patient models, methods, and cohorts, and how to validation them. |
| Q47146683 | Non-diabetic Hyperglycemia and Some of Its Correlates in ICU Hospitalized Patients Receiving Enteral Nutrition |
| Q48250698 | Nutrition delivery of a model-based ICU glycaemic control system |
| Q37292173 | Nutrition support challenges in hematopoietic stem cell transplant patients |
| Q44313142 | Optimizing Inpatient Glycemic Control with Basal-Bolus Insulin Therapy |
| Q42597934 | Overview of glycemic control in critical care: relating performance and clinical results |
| Q36942161 | Pathways to Quality Inpatient Management of Hyperglycemia and Diabetes: A Call to Action |
| Q39383810 | Pilot proof of concept clinical trials of Stochastic Targeted (STAR) glycemic control |
| Q37590223 | Post-resuscitation care: current therapeutic concepts |
| Q36748988 | Pro/con debate: Is intensive insulin therapy targeting tight blood glucose control of benefit in critically ill patients? |
| Q41884330 | Quality and performance improvement in critical care |
| Q37628557 | Recent progress in mechanical artificial pancreas |
| Q37335146 | Relationship between perioperative glycemic control and postoperative infections |
| Q42874562 | Safe Insulin Use in the Hospital Setting |
| Q37070147 | Safety and efficacy of continuous insulin infusion in noncritical care settings |
| Q39636410 | Safety, efficacy and clinical generalization of the STAR protocol: a retrospective analysis |
| Q35874155 | Stochastic targeted (STAR) glycemic control: design, safety, and performance |
| Q46775954 | Strategies for success: A PDSA analysis of three QI initiatives in critical care |
| Q36492485 | Study of a structured action pathway and persistent monitoring tool among nurses to achieve cent percent management of hypoglycaemia in in-patients: A measure of quality of healthcare |
| Q38676372 | The Case for Diabetes Population Health Improvement: Evidence-Based Programming for Population Outcomes in Diabetes. |
| Q37915625 | The economic and clinical benefits of adequate insulin initiation and intensification in people with type 2 diabetes mellitus |
| Q37824670 | The economics of glycemic control in the ICU in the United States |
| Q42118689 | The need for continuous blood glucose monitoring in the intensive care unit |
| Q36813092 | The postoperative care of adult patients exposed to deep hypothermic circulatory arrest |
| Q36742049 | Therapy insight: the effect of tight glycemic control in acute illness |
| Q37663614 | Tight perioperative glycemic control using an artificial endocrine pancreas |
| Q37876075 | Understanding Glycemic Control in the Critically Ill: 2011 Update |
| Q36769694 | Update in critical care 2006. |
| Q35575260 | Validation of a model-based virtual trials method for tight glycemic control in intensive care. |
| Q26852360 | Vascular Glucose Sensor Symposium: Continuous Glucose Monitoring Systems (CGMS) for Hospitalized and Ambulatory Patients at Risk for Hyperglycemia, Hypoglycemia, and Glycemic Variability |
Search more.